Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Data : 15/04/2019 @ 17:26
Fonte : UK Regulatory (RNS & others)
Titolo : Hikma Pharmaceuticals Plc (HIK)
Quotazione : 1883.5  6.5 (0.35%) @ 14:58
Quotazione Hikma Pharmaceuticals Grafico

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico

1 Anno : Da Nov 2018 a Nov 2019

Clicca qui per i Grafici di Hikma Pharmaceuticals

TIDMHIK

RNS Number : 2519W

Hikma Pharmaceuticals Plc

15 April 2019

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 15 April 2019: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 13 April 2017 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 15 April 2019.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 15 April 2019 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 60,973 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   15 April 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 15 April 2019 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 33,005 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   15 April 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Riad Mishlawi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the             Shares acquired from vesting of the nil-cost 
     transaction               option on 
                               15 April 2019 under the 2014 EIP Element B. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 22,241 
d)  Aggregated information   N/A 
e)  Date of the transaction   15 April 2019 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Majda Labadi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Majda Labadi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the             Shares acquired from vesting of the conditional 
     transaction               awards on 
                               15 April 2019 under the 2014 EIP Element B. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 17,825 
d)  Aggregated information   N/A 
e)  Date of the transaction   15 April 2019 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 15 April 2019 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 27,578 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   15 April 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 15 April 2019 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 26,174 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   15 April 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBUGDSDDBBGCU

(END) Dow Jones Newswires

April 15, 2019 11:26 ET (15:26 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20191115 14:13:38